Publisher： Bentham Science Publishers
E-ISSN： 1873-4316|13|10|2022-2025
ISSN： 1389-2010
Source： Current Pharmaceutical Biotechnology, Vol.13, Iss.10, 2012-08, pp. : 2022-2025
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Mouse Models of Primary Sjogren’s Syndrome
Current Pharmaceutical Design, Vol. 21, Iss. 18, 2015-06 ,pp. :
Access to resources
Recommend
Current and Future Challenges in Primary Sjogren's Syndrome
Current Pharmaceutical Biotechnology, Vol. 13, Iss. 10, 2012-08 ,pp. :
Primary Sjogren's Syndrome and the Type I Interferon System
Current Pharmaceutical Biotechnology, Vol. 13, Iss. 10, 2012-08 ,pp. :
Anti-CD20 Antibody in Primary Sjogren’s Syndrome Management
Current Pharmaceutical Biotechnology, Vol. 15, Iss. 6, 2014-06 ,pp. :